Over the weekend, six members of the Presidential Advisory Council on HIV/AIDS (PACHA) resigned in protest of the American Health Care Act bill, saying Trump “doesn’t care” about people living with HIV. Founded in 1995, PACHA advises the president and the Secretary of Health and Human Services on healthcare policies…
Scientists are excited about the prospect of using CRISPR, a powerful gene-editing tool, to combat HIV. A discouraging follow-up study shows that HIV is capable of developing a resistance to the genetic attack—but scientists say CRISPR’s battle with HIV is far from over.
The HIV infection rate among African American and Latina women in Southern states now rivals that of sub-Saharan Africa. Although most of those patients rely on Medicaid, the nine Deep South states with the highest infection and fatality rates have not opted to expand the program under the Affordable Care Act.
European researchers have used a computer to design small synthetic molecules capable of attacking the deadly AIDS virus where it hurts the most: its ability to produce the genetic material required for replication. It's the first time in history this has ever been done.
In a breakthrough six years in the making, an international team of researchers has determined the precise atomic structure of a cell-surface receptor that’s used by most strains of HIV to infect human immune cells. The finding could result in medicines that block the process.
Earlier this month, doctors announced that a baby had been cured of an HIV infection. Now, using a similar technique, it appears that 14 adults have likewise been successfully treated for the disease. The trick, say the scientists, is to tackle the infection early.
Canadian researchers working to develop the world's first HIV vaccine announced on Tuesday that they have cleared a major hurdle. Initial results from a Phase I trial conducted by scientists at Western University has shown no adverse effects while significantly boosting immunity. The vaccine, which is based on a…